Recruiting
Phase 2

Targeted Therapy

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05564377

Conditions

Advanced Malignant Solid Neoplasm

Anatomic Stage III Breast Cancer AJCC v8

Anatomic Stage IV Breast Cancer AJCC v8

Locally Advanced Malignant Solid Neoplasm

Malignant Female Reproductive System Neoplasm

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Alpelisib

Binimetinib

Biopsy Procedure

Biospecimen Collection

Bone Marrow Aspiration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-05-30.